investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Immune Evolution in Cancer

David L Woodland

1 Collaborator(s)

Funding source

National Cancer Institute (NIH)

No posts

Related projects

Ulf Klein

The Role of NF-kB in B-Cell Differentiation and Lymphomagenesis

Non-Hodgkin lymphoma

Pathology Hematology and hematologic malignancies

Dipanjan Chowdhury

Molecular mechanism and relevance of microRNAs in DSB repair pathway choice

Non-Hodgkin lymphoma

Pathology Hematology and hematologic malignancies

Daniel Fowler

Combination Gene Therapy and Th1/Th2 Therapy

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

John Nicholas

BH3-only Protein Targeting by HHV-8

Non-Hodgkin lymphoma

Pathology

Nathanael S Gray

MALT1 inhibitors for the treatment of chemo-resistant ABC-DLBCL

Non-Hodgkin lymphoma

Pathology Hematology and hematologic malignancies

Timothy A Springer

Integrin-Targeted siRNA Delivery for Therapeutic Gene Silencing in Blood Cancers

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies

Riccardo Dalla-Favera

Role of Acetyltransferase Gene Inactivation in Follicular Lymphoma Pathogenesis

Non-Hodgkin lymphoma

Pathology Hematology and hematologic malignancies

Kelvin P Lee

CD28-Mediated Regulation of Multiple Myeloma Cell Proliferation and Survival

Multiple myeloma and immunoproliferative diseases

Pathology Hematology and hematologic malignancies

William Figg

Using Clinical Pharmacology Principles to Develop New Anticancer Therapies

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology